Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Genetic Lingo01:11

Genetic Lingo

118.1K
Overview
118.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

11.1K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.1K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study.

The journal of prevention of Alzheimer's disease·2026
Same author

New Guidelines for Ophthalmic Genetic Studies.

Investigative ophthalmology & visual science·2026
Same author

Genome-Wide Association Study for Glucocorticoid-Induced Ocular Hypertension.

Ophthalmology science·2026
Same author

Transcending genome-wide association studies to create useful multi-omic views of glaucoma.

Progress in retinal and eye research·2026
Same author

A Primary Open-Angle Glaucoma Locus Near Transcription Factor <i>PRRX1</i> Identified in the Million Veteran Program.

Ophthalmology science·2026
Same author

Primary Open Angle Glaucoma Polygenic Risk Score is Associated with Disease Progression.

Ophthalmology. Glaucoma·2026

Related Experiment Video

Updated: Apr 5, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

10.0K

Glaucoma Genes and Mechanisms.

Janey L Wiggs1

  • 1Harvard Medical School, and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Progress in Molecular Biology and Translational Science
|August 28, 2015
PubMed
Summary
This summary is machine-generated.

Genetic research identifies key genes for early and adult-onset glaucoma. These genes impact various cellular functions, offering insights for developing gene-based glaucoma therapies.

Keywords:
AutophagyCaveolinsComplex traitExtracellular matrixGlaucomaInheritanceLipid metabolismMendelian traitNOS3Ocular developmentRegulation of cell cycleTGF-betaTNF-alpha

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.8K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Related Experiment Videos

Last Updated: Apr 5, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

10.0K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.8K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Genetic factors play a significant role in both early-onset and adult-onset glaucoma.
  • Understanding the molecular mechanisms of glaucoma is crucial for therapeutic development.

Purpose of the Study:

  • To review and organize genes associated with glaucoma based on their cellular functions.
  • To provide insights into the biological pathways affected in glaucoma pathogenesis.
  • To highlight the potential for gene-based therapeutic strategies.

Main Methods:

  • Comprehensive literature review of genetic studies on glaucoma.
  • Categorization of identified glaucoma genes by their protein products' biological functions and affected cellular processes.
  • Synthesis of current knowledge on gene function in glaucoma pathogenesis.

Main Results:

  • Identified numerous genes contributing to early-onset and adult-onset glaucoma.
  • Found that glaucoma-related proteins are involved in diverse cellular processes including extracellular matrix, cytokine signaling, lipid metabolism, and cell division.
  • Highlighted that approximately half of these genes function in the extracellular matrix.

Conclusions:

  • Genetic studies have elucidated key genes involved in glaucoma.
  • The diverse functions of these genes underscore the complexity of glaucoma pathogenesis.
  • Further understanding of these gene functions is essential for advancing gene-based glaucoma therapies.